RISE ‐ Ethiopia.
| Trial name or title | RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia). |
| Methods | Cluster randomised trial. |
| Participants | Adults with a diagnosis of schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder, or schizophreniform disorder) using (DSM‐IV) criteria. |
| Interventions | 1. Communitybased rehabilitation: delivered to participants and their caregivers at their home, comprising psycho‐education, adherence support, rehabilitation (including self care and social skills), family support groups, and accessing existing community organisations. The intervention also involves community awareness raising and education and mobilisation of community leaders; antipsychotic medication prescribed by a nurse or clinical officer in a health centre; and basic psycho‐education. 2. Facility‐based usual care: antipsychotic medication prescribed by a nurse or clinical officer in a health centre and basic psycho‐education. |
| Outcomes | Disability, symptom severity, Clinical Global Impression, relapse, functioning, economic activity of participant (employment, income, and household work), medication adherence, engagement with facility‐based care, proportion with human rights problems, nutritional status (BMI), serious adverse events, etc. |
| Starting date | September 2015. |
| Contact information | Mary De Silva, PhD MSc, London School of Hygiene and Tropical Medicine. Abebaw Fekadu, Addis Ababa University Department of Psychiatry. |
| Notes | Currently recruiting. |